Continuous subcutaneous administration of the N-methyl-D-aspartic acid (NMDA) receptor antagonist ketamine in the treatment of post-herpetic neuralgia (Q39475248)
scientific article published on May 1995
Language:
Current Data About Continuous subcutaneous administration of the N-methyl-D-aspartic acid (NMDA) receptor antagonist ketamine in the treatment of post-herpetic neuralgia
(P31) (Q13442814)
(P248)
(P698) 7659432
(P813) Tuesday, September 12, 2017

(P50) (Q16179750)
(P1932) H Breivik
(P1545) 4

(Q47013981)
(P1545) 2
(P1932) A Stubhaug
(P248)
(P698) 7659432
(P813) Tuesday, September 12, 2017

(P304) 221-228
(P248)
(P698) 7659432
(P813) Tuesday, September 12, 2017

(P407) (Q1860)

(P433) 2
(P248)
(P698) 7659432
(P813) Tuesday, September 12, 2017

(P478) 61
(P248)
(P698) 7659432
(P813) Tuesday, September 12, 2017

(P577) Monday, May 1, 1995
(P248)
(P698) 7659432
(P813) Tuesday, September 12, 2017

(P1433) (Q2317902)
(P248)
(P698) 7659432
(P813) Tuesday, September 12, 2017

(P1476) "Continuous subcutaneous administration of the N-methyl-D-aspartic acid (NMDA) receptor antagonist ketamine in the treatment of post-herpetic neuralgia" (language: en)
(P248)
(P698) 7659432
(P813) Tuesday, September 12, 2017

(P2093) K Eide
(P1545) 1
(P248)
(P698) 7659432
(P813) Tuesday, September 12, 2017

I Oye
(P1545) 3
(P248)
(P698) 7659432
(P813) Tuesday, September 12, 2017

other details
description scientific article published on May 1995

External Links
(P356) 10.1016/0304-3959(94)00182-E
(P698) 7659432
(P8608) release_rjmrmva5i5aqln74u2xy6zrquq